These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 5859609)

  • 1. [On the pressurizing process in tablet making. 4. Studies on the dependence of pressure on density in eccentric pressing and on the pressure distribution in the column of material].
    Führer C
    Dtsch Apoth Ztg; 1965 Aug; 105(34):1150-3. PubMed ID: 5859609
    [No Abstract]   [Full Text] [Related]  

  • 2. [The pharmaceutical technology of tablet making. Physical processes taking place during tablet formation and the effect of pressure on properties of the tablets].
    Moldenhauer H; Kala H; Zessin G; Dittgen M
    Pharmazie; 1980; 35(11):714-26. PubMed ID: 7465618
    [No Abstract]   [Full Text] [Related]  

  • 3. [Program in the manufacturing and control of tablets. XIII. Transfer of forces and distribution of tension during the pressing process].
    Rak J; Chalabala M
    Cesk Farm; 1975 Jan; 24(1):28-33. PubMed ID: 1139648
    [No Abstract]   [Full Text] [Related]  

  • 4. A material-sparing method for simultaneous determination of true density and powder compaction properties--aspartame as an example.
    Sun CC
    Int J Pharm; 2006 Dec; 326(1-2):94-9. PubMed ID: 16926076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Influence of the pressing force on the physical features of sulfathiazole tablets and the dissolution rate of the active ingredient].
    Miseta M; Kedvessy G; Selmeczi B
    Pharmazie; 1983 May; 38(5):326-7. PubMed ID: 6611630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative measurements of localized density variations in cylindrical tablets using X-ray microtomography.
    Busignies V; Leclerc B; Porion P; Evesque P; Couarraze G; Tchoreloff P
    Eur J Pharm Biopharm; 2006 Aug; 64(1):38-50. PubMed ID: 16621489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring the distribution of density and tabletting force in pharmaceutical tablets by chemical imaging.
    Ellison CD; Ennis BJ; Hamad ML; Lyon RC
    J Pharm Biomed Anal; 2008 Sep; 48(1):1-7. PubMed ID: 18539424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dynamic forces arising during pressing of drug powders. The instrumentation of the tablet pressing machine necessary for the measurements].
    Kovács B; Merényi G; Pandula E
    Acta Pharm Hung; 1970; 40(5):223-5. PubMed ID: 5482253
    [No Abstract]   [Full Text] [Related]  

  • 9. [Influence of lubricants on the pressing-power distribution in comprimates].
    Hüttenrauch R; Jacob J
    Pharmazie; 1977 Jan; 32(1):49-50. PubMed ID: 840882
    [No Abstract]   [Full Text] [Related]  

  • 10. [The role of the pressure curves in tablet pressing in the development of tablet production].
    Kovács B; Szabó S; Gyarmati L
    Acta Pharm Hung; 1976 Jan; 46(1):31-6. PubMed ID: 1258650
    [No Abstract]   [Full Text] [Related]  

  • 11. [Recrystallization of active solids during pressing].
    Hüttenrauch R; Keiner I
    Pharmazie; 1977 Feb; 32(2):129-30. PubMed ID: 859911
    [No Abstract]   [Full Text] [Related]  

  • 12. [The reaction rate of tablet formation].
    Hüttenrauch R; Dietze U
    Pharmazie; 1977 Jan; 32(1):47-8. PubMed ID: 840880
    [No Abstract]   [Full Text] [Related]  

  • 13. [Tablet making machines for the pharmacy practice].
    van Waert JH
    Pharm Weekbl; 1972 Dec; 107(49):783-91. PubMed ID: 4653011
    [No Abstract]   [Full Text] [Related]  

  • 14. [Molecular galenics. 16. The increase of inner energy in a stable system by single and multiple pressing].
    Hüttenrauch R; Keiner I
    Pharmazie; 1976; 31(9):653-4. PubMed ID: 1019220
    [No Abstract]   [Full Text] [Related]  

  • 15. [Progress in the manufacturing and control of tablets. XV. Mathematical interpretation of the pressure process].
    Rak J; Chalabala M
    Cesk Farm; 1975 Mar; 24(2):84-91. PubMed ID: 1157104
    [No Abstract]   [Full Text] [Related]  

  • 16. Development and evaluation of a novel dry-coated tablet technology for pellets as a substitute for the conventional encapsulation technology.
    Ando M; Kojima S; Ozeki Y; Nakayama Y; Nabeshima T
    Int J Pharm; 2007 May; 336(1):99-107. PubMed ID: 17223295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Particle size distribution and evolution in tablet structure during and after compaction.
    Fichtner F; Rasmuson A; Alderborn G
    Int J Pharm; 2005 Mar; 292(1-2):211-25. PubMed ID: 15725568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Albizia zygia gum as a binding agent in tablet formulations.
    Odeku OA
    Acta Pharm; 2005 Sep; 55(3):263-76. PubMed ID: 16375837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tableting and tablet properties of alginates: characterisation and potential for Soft Tableting.
    Schmid W; Picker-Freyer KM
    Eur J Pharm Biopharm; 2009 May; 72(1):165-72. PubMed ID: 18992337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.